Insider Trading - Monte Rosa Therapeutics Inc. (GLUE)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Monte Rosa Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-28
Purchase
2021-06-30
4:08 pm
Monte Rosa Therapeutics Inc. GLUE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund III LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
600,000 $19 $11,400,000 3,202,200
(Indirect)
View
2021-06-28
Purchase
2021-06-30
5:00 pm
Monte Rosa Therapeutics Inc. GLUE Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
157,895 $19 $3,000,005 8,897,053
(Indirect
Direct)
View
2021-06-28
Purchase
2021-06-30
5:05 pm
Monte Rosa Therapeutics Inc. GLUE Bolzon Bradley J PhD
Director
10% Owner
157,895 $19 $3,000,005 2,097,938
(Indirect)
View
2021-06-28
Purchase
2021-06-30
5:59 pm
Monte Rosa Therapeutics Inc. GLUE New Enterprise Associates 17 L.P.
NEA Partners 17 L.P.
NEA 17 GP LLC
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Direct)
View
2021-06-28
Purchase
2021-06-30
6:00 pm
Monte Rosa Therapeutics Inc. GLUE BASKETT FOREST
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:01 pm
Monte Rosa Therapeutics Inc. GLUE Behbahani Ali
Director
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:02 pm
Monte Rosa Therapeutics Inc. GLUE Chang Carmen
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:02 pm
Monte Rosa Therapeutics Inc. GLUE Florence Anthony A. Jr.
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:04 pm
Monte Rosa Therapeutics Inc. GLUE Landsman Liza
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:05 pm
Monte Rosa Therapeutics Inc. GLUE Makhzoumi Mohamad
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:06 pm
Monte Rosa Therapeutics Inc. GLUE MAKOWER JOSHUA
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:06 pm
Monte Rosa Therapeutics Inc. GLUE Mathers Edward T
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:07 pm
Monte Rosa Therapeutics Inc. GLUE SANDELL SCOTT D
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:08 pm
Monte Rosa Therapeutics Inc. GLUE Sonsini Peter W.
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:08 pm
Monte Rosa Therapeutics Inc. GLUE Walker Paul Edward
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:09 pm
Monte Rosa Therapeutics Inc. GLUE Yang Rick
10% Owner
1,050,000 $19 $19,950,000 7,692,298
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-06-23
Option Award
2021-06-25
5:00 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc. GLUE Mayweg Alexander
Director
47,132 $0 47,132
(Direct)
View
2021-02-24
Option Award
2021-06-25
5:00 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc. GLUE Bolzon Bradley J PhD
Director
10% Owner
47,132 $0 9,896,460
(Direct)
View
2021-02-24
Option Award
2021-06-25
5:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Bolzon Bradley J PhD
Director
10% Owner
3,575,000 $2 9,896,460
(Indirect)
View
2021-02-24
Option Award
2021-06-25
5:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Bolzon Bradley J PhD
Director
10% Owner
2,699,328 $2.9637 9,896,460
(Indirect)
View
2021-06-23
Option Award
2021-06-25
5:00 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc. GLUE Janku Filip
Chief Medical Officer
387,069 $0 387,069
(Direct)
View
2021-04-12
Option Award
2021-06-25
5:00 pm
N/A
2031-04-12
Monte Rosa Therapeutics Inc. GLUE Wallace Owen B.
Chief Scientific Officer
500,367 $0 500,367
(Direct)
View
2021-04-12
Option Award
2021-06-25
5:00 pm
N/A
2031-04-12
Monte Rosa Therapeutics Inc. GLUE Warmuth Markus
Director
680,140 $0 680,140
(Direct)
View
2021-04-12
Option Award
2021-06-25
5:00 pm
N/A
2031-04-12
Monte Rosa Therapeutics Inc. GLUE Blackwell Kimberly
Director
54,213 $0 54,213
(Direct)
View
2021-04-12
Option Award
2021-06-25
5:01 pm
N/A
2031-04-12
Monte Rosa Therapeutics Inc. GLUE Siu Christine
Director
54,213 $0 54,213
(Direct)
View
2021-06-23
Option Award
2021-06-25
5:01 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc. GLUE SCHIFF ANDREW N
Director
47,132 $0 47,132
(Direct)
View
2021-06-23
Option Award
2021-06-25
5:01 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc. GLUE Leo Chandra P.
Director
47,132 $0 47,132
(Direct)
View
2021-04-12
Option Award
2021-06-25
5:01 pm
N/A
2031-04-12
Monte Rosa Therapeutics Inc. GLUE Tamboli Ajim
CFO
157,587 $0 157,587
(Direct)
View
2021-06-23
Option Award
2021-06-25
5:47 pm
N/A
2031-06-22
Monte Rosa Therapeutics Inc. GLUE Behbahani Ali
Director
10% Owner
47,132 $0 47,132
(Direct)
View
2021-06-28
Conversion
2021-06-30
4:08 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Cormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund III LP
Cormorant Private Healthcare Fund II LP
Former 10% Owner
5,204,400 $0 3,202,200
(Indirect)
View
2021-06-28
Conversion
2021-06-30
5:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
38,309,520 $0 8,897,053
(Direct)
View
2021-06-28
Conversion
2021-06-30
5:05 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Bolzon Bradley J PhD
Director
10% Owner
38,309,520 $0 2,097,938
(Indirect)
View
2021-06-28
Conversion
2021-06-30
5:59 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE New Enterprise Associates 17 L.P.
NEA Partners 17 L.P.
NEA 17 GP LLC
10% Owner
30,092,935 $0 7,692,298
(Direct)
View
2021-06-28
Conversion
2021-06-30
6:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE BASKETT FOREST
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:01 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Behbahani Ali
Director
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:02 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Chang Carmen
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:02 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Florence Anthony A. Jr.
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:04 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Landsman Liza
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:05 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Makhzoumi Mohamad
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:06 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE MAKOWER JOSHUA
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:06 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Mathers Edward T
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:07 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE SANDELL SCOTT D
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:08 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Sonsini Peter W.
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:08 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Walker Paul Edward
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:09 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Yang Rick
10% Owner
30,092,935 $0 7,692,298
(Indirect)
View